V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037229 | 210007332 | 1.77 | 87.3 | Curative (C) | null | 2015-06-26 | UKALL14- Cons Cycle 3 | N | N | 210013011 | UKALL2014 |
| 210037230 | 210007337 | 1.89 | 58.9 | Disease modification (D) | 2017-07-22 | 2017-09-13 | UKALL 14 TRIAL | null | null | 210013032 | UKALL2014 |
| 210037231 | 210007344 | 1.82 | null | Adjuvant (A) | 2017-09-06 | 2017-09-17 | UKALL14- Ph 2 Induction + Imatinib | 01 | N | 210013035 | UKALL2014 |
| 210037232 | 210007354 | 1.64 | 92 | Disease modification (D) | 2015-10-27 | 2015-10-28 | UKALL14- Intens/CNS Proph +Imatinib | Y | N | 210013045 | UKALL2014 |
| 210037233 | 210007358 | 1.8 | 74.5 | Curative (C) | 2017-09-12 | 2018-03-20 | UKALL14- Maintenance | Y | N | 210013090 | UKALL2014 |
| 210037234 | 210007369 | 1.71 | 72 | Curative (C) | null | 2014-07-27 | UKALL14- Cons Cycle 3 | N | N | 210013093 | UKALL2014 |
| 210037235 | 210018997 | 1.78 | 76 | Curative (C) | null | 2017-04-04 | UKALL14- Ph 1 Induction | Y | N | 210013114 | UKALL2014 |
| 210037236 | 210007386 | 1.56 | 58.8 | Curative (C) | 2014-08-11 | 2014-11-15 | UKALL14- Cons Cycle 2 | 01 | N | 210013117 | UKALL2014 |
| 210037237 | 210007392 | 1.93 | 95.4 | Curative (C) | 2013-06-30 | 2016-11-18 | UKALL14- Maintenance | N | N | 210013124 | UKALL2014 |
| 210037238 | 210007404 | 1.66 | 57.7 | Curative (C) | 2018-05-19 | 2019-01-26 | UKALL 14 TRIAL | 01 | N | 210013144 | UKALL2014 |
| 210037239 | 210007411 | 1.8 | 71.8 | Palliative (P) | null | 2018-08-22 | UKALL14- Maintenance | N | N | 210013154 | UKALL2014 |
| 210037240 | 210007416 | 0 | 91.5 | null | 2014-07-04 | 2014-07-07 | UKALL 14 TRIAL | Y | Y | 210013173 | UKALL2014 |
| 210037241 | 210007425 | 1.93 | 94 | Curative (C) | 2017-10-24 | 2017-11-18 | UKALL14- Intens/CNS Proph +Imatinib | Y | N | 210013202 | UKALL2014 |
| 210037242 | 210007429 | 1.69 | 74 | Palliative (P) | 2016-02-28 | 2016-06-10 | UKALL14- Maintenance | Y | N | 210013223 | UKALL2014 |
| 210037243 | 210007442 | 1.58 | 46.8 | Curative (C) | 2018-12-19 | 2019-04-04 | UKALL14- Cons Cycle 2 | N | N | 210013233 | UKALL2014 |
| 210037244 | 210007455 | 1.68 | 64 | Curative (C) | 2019-04-02 | 2019-07-09 | UKALL 14 TRIAL | 01 | N | 210013286 | UKALL2014 |
| 210037245 | 210019023 | 1.51 | 101 | Curative (C) | 2017-09-28 | 2017-09-28 | UKALL14- Cons Cycle 1 | 02 | N | 210013297 | UKALL2014 |
| 210037246 | 210007467 | 1.56 | null | Curative (C) | 2014-10-07 | 2015-08-10 | UKALL14- Maintenance | Y | N | 210013298 | UKALL2014 |
| 210037248 | 210033133 | 1.77 | 69.5 | Curative (C) | 2016-08-30 | 2018-08-18 | UKALL14- Intens/CNS Proph +Imatinib | Y | N | 210013419 | UKALL2014 |
| 210037249 | 210007501 | 1.68 | 79 | Curative (C) | null | 2018-04-17 | UKALL14- Maintenance | Y | N | 210013427 | UKALL2014 |
| 210037250 | 210007512 | 1.78 | 75.3 | Curative (C) | 2014-07-21 | 2014-07-29 | UKALL14- Cons Cycle 1 | 01 | N | 210013469 | UKALL2014 |
| 210037251 | 210007520 | 1.84 | 68 | Curative (C) | 2017-03-18 | 2017-04-21 | UKALL14- Intens/CNS Proph | 02 | N | 210013478 | UKALL2014 |
| 210037252 | 210007525 | null | 75 | Curative (C) | null | 2015-11-29 | UKALL14- FMC (1 day) Conditioning | Y | null | 210013481 | UKALL2014 |
| 210037253 | 210019049 | null | 9 | Curative (C) | 2016-03-15 | 2017-04-28 | CNS Infant MBL Car/Etop | N | N | 210013538 | NOT MATCHED |
| 210037254 | 210007545 | 1.7 | 17.9 | Curative (C) | 2017-09-15 | 2018-06-14 | CNS Headstart II A Ind 4,5 int | 01 | N | 210013548 | NOT MATCHED |
| 210037255 | 210007549 | null | 16.9 | Disease modification (D) | 2014-04-07 | 2014-08-18 | CNS ATRT Carboplatin/Thiotepa + GCSF | Y | N | 210013562 | NOT MATCHED |
| 210037257 | 210007559 | 1.45 | null | Curative (C) | 2015-05-24 | 2015-08-30 | CNS Infant MBL HDMTX | Y | N | 210013588 | NOT MATCHED |
| 210037258 | 210007567 | null | 18.5 | Curative (C) | 2017-12-26 | 2018-05-19 | CNS Ependymoma II Cisplatin | Y | N | 210013589 | NOT MATCHED |
| 210037260 | 210007587 | null | 28.8 | Curative (C) | 2015-10-26 | 2015-12-12 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | Y | null | 210013639 | NOT MATCHED |
| 210037261 | 210007591 | 0 | 56 | Curative (C) | 2018-11-29 | 2019-02-22 | CNS Headstart II Myeloablation | 02 | N | 210013640 | NOT MATCHED |
| 210037262 | 210007600 | 0 | 16.2 | Curative (C) | 2015-10-22 | 2015-12-11 | CISPLATIN + CYCLOPHOSPHAMIDE + VINCRISTINE | N | N | 210013643 | NOT MATCHED |
| 210037263 | 210007610 | null | 9 | Curative (C) | 2014-01-09 | 2014-03-06 | CNS LGG 2004 03 cons vinc +cyclo | N | null | 210013655 | NOT MATCHED |
| 210037264 | 210007617 | null | 37.3 | null | 2017-01-14 | 2017-01-24 | CNS Choriod Plexus SIOP 2009, CycEV | 2 | null | 210013660 | NOT MATCHED |
| 210037265 | 210007641 | 1.76 | 32.2 | Curative (C) | 2018-08-19 | 2018-08-31 | CNS Headstart II Myeloablation | null | N | 210013724 | NOT MATCHED |
| 210037266 | 210019087 | 0 | 67.4 | Curative (C) | null | 2016-12-04 | ALL Int Guide B Ind Ph 1 PegAsp | 1 | N | 210013727 | NOT MATCHED |
| 210037267 | 210019091 | null | null | Curative (C) | 2013-09-18 | 2013-09-21 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | Y | N | 210013740 | NOT MATCHED |
| 210037268 | 210007657 | null | 49.3 | Curative (C) | 2018-07-21 | 2018-08-23 | NB Rel CCLG guidelines Cyclo-Topotecan | N | N | 210013754 | NOT MATCHED |
| 210037269 | 210007668 | null | 66.3 | Curative (C) | 2014-01-28 | 2014-01-28 | CNS High Grade Glioma PCV | Y | N | 210013789 | NOT MATCHED |
| 210037270 | 210007691 | 0 | 12 | Curative (C) | 2017-03-04 | 2017-12-25 | CNS Infant MBL Car/Etop | Y | N | 210013846 | NOT MATCHED |
| 210037271 | 210007703 | null | 9.3 | Curative (C) | 2017-04-12 | 2018-01-31 | CNS Infant MBL Car/Etop | 02 | N | 210013874 | NOT MATCHED |
| 210037272 | 210007710 | null | 9.9 | Curative (C) | 2016-06-20 | 2016-07-21 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | Y | N | 210013876 | NOT MATCHED |
| 210037273 | 210007717 | null | 19.7 | Curative (C) | 2017-06-29 | 2017-07-07 | CNS Infant MBL Vinc/Cyclo | N | null | 210013886 | NOT MATCHED |
| 210037274 | 210007720 | null | 36.3 | Curative (C) | 2017-01-21 | 2017-03-06 | CNS Epen2007 09 Baby Brn vinc+carbo | Y | N | 210013889 | NOT MATCHED |
| 210037275 | 210007727 | 1.08 | null | Curative (C) | 2014-08-11 | 2014-08-11 | CNS Epen2007 09 Baby Brn cisplatin | N | N | 210013914 | NOT MATCHED |
| 210037276 | 210007736 | null | 9.9 | Curative (C) | 2015-11-20 | 2016-02-03 | CNS High Grade Glioma PCV | 01 | N | 210013926 | NOT MATCHED |
| 210037277 | 210007742 | 0 | 68.4 | Curative (C) | 2015-12-23 | 2015-12-25 | CNS ATRT VCA | N | null | 210013932 | NOT MATCHED |
| 210037278 | 210007748 | 0.8 | 16.7 | Curative (C) | 2015-05-17 | 2016-02-02 | CNS Epen2007 09 Baby Brn vinc+carbo | N | N | 210013944 | NOT MATCHED |
| 210037280 | 210007764 | 1.54 | null | Curative (C) | 2016-07-22 | 2016-07-23 | null | 02 | null | 210013990 | NOT MATCHED |
| 210037281 | 210007782 | 1.78 | 16.8 | Curative (C) | 2017-06-18 | 2018-02-11 | CNS Infant MBL Car/Etop | Y | N | 210014025 | NOT MATCHED |
| 210037282 | 210007790 | null | 7.9 | Disease modification (D) | 2018-08-18 | 2018-08-31 | ALL Ph+ve Cons HR2 Pasp | 02 | Y | 210014046 | NOT MATCHED |